RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Patient’s Self-recognition of Reduced Visual Acuity Due to Recurrence of Macular Edema and Prompt Visitation to the Hospital in Retinal Vein Occlusion

      한글로보기

      https://www.riss.kr/link?id=A103855916

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: To evaluate patients’ self-recognition of reduced visual acuity due to recurring macular edema in retinalvein occlusion. Methods: A retrospective review of medical records of patients who were diagnosed with recurring macularedema secondary...

      Purpose: To evaluate patients’ self-recognition of reduced visual acuity due to recurring macular edema in retinalvein occlusion.
      Methods: A retrospective review of medical records of patients who were diagnosed with recurring macularedema secondary to retinal vein occlusion was performed. The proportion of patients who recognized reducedvisual acuity due to the recurrence of macular edema and who visited the hospital before the scheduledfollow-up date was determined. Parameters including age, sex, diagnosis, visual acuity before recurrenceof macular edema, and extent of visual acuity reduction due to recurrence of macular edema were comparedin patients who recognized a reduction in visual acuity and those who did not. The proportion of patients whovisited the hospital promptly was also determined.
      Results: Forty eyes of 40 patients were included in the analysis. Sixteen and 24 patients were diagnosed withcentral retinal vein occlusion and branch retinal vein occlusion, respectively. Twenty-one patients (52.5%) recognizedreduced visual acuity due to recurring macular edema. These patients were younger (59.2 ± 7.6 vs.
      64.8 ± 9.4 years, p = 0.046), had better visual acuity before recurrence of macular edema (0.52 ± 0.48 vs. 1.02± 0.46, p = 0.002), and exhibited a greater reduction in visual acuity after recurrence of macular edema (0.34± 0.24 vs. 0.14 ± 0.13, p = 0.003). Only four patients visited the hospital before the scheduled follow-up date,and all of these patients lived relatively close to the hospital.
      Conclusions: For prompt treatment of recurring macular edema, more intensive education about the self-estimationof visual acuity is necessary, particularly for elderly patients who have relatively poor visual acuity. Inaddition, a simple and easy way to identify the recurrence of macular edema at the local clinic should be establishedfor patients who live relatively far from the hospital.

      더보기

      참고문헌 (Reference)

      1 신혜영, "망막중심정맥폐쇄에 동반된 황반부종에서 라니비주맙 주입술의 단기 임상 효과" 대한안과학회 52 (52): 1048-1054, 2011

      2 Brown DM, "Ranibizumab for macular edema following central retinal vein occlusion:six-month primary end point results of a phase III study" 117 : 1124-1133, 2010

      3 Campochiaro PA, "Ranibizumab for macular edema following branch retinal vein occlusion:six-month primary end point results of a phase III study" 117 : 1102-1112, 2010

      4 Campochiaro PA, "Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator" 16 : 791-799, 2008

      5 Haller JA, "Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion" 117 : 1134-1146, 2010

      6 Yang CS, "Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography" 79 : 266-270, 2001

      7 Schaudig UH, "Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema" 31 : 182-186, 2000

      8 Gregori NZ, "One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion" 26 : 889-895, 2006

      9 McIntosh RL, "Natural history of central retinal vein occlusion: an evidence-based systematic review" 117 : 1113-1123, 2010

      10 Rogers SL, "Natural history of branch retinal vein occlusion: an evidence-based systematic review" 117 : 1094-1101, 2010

      1 신혜영, "망막중심정맥폐쇄에 동반된 황반부종에서 라니비주맙 주입술의 단기 임상 효과" 대한안과학회 52 (52): 1048-1054, 2011

      2 Brown DM, "Ranibizumab for macular edema following central retinal vein occlusion:six-month primary end point results of a phase III study" 117 : 1124-1133, 2010

      3 Campochiaro PA, "Ranibizumab for macular edema following branch retinal vein occlusion:six-month primary end point results of a phase III study" 117 : 1102-1112, 2010

      4 Campochiaro PA, "Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator" 16 : 791-799, 2008

      5 Haller JA, "Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion" 117 : 1134-1146, 2010

      6 Yang CS, "Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography" 79 : 266-270, 2001

      7 Schaudig UH, "Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema" 31 : 182-186, 2000

      8 Gregori NZ, "One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion" 26 : 889-895, 2006

      9 McIntosh RL, "Natural history of central retinal vein occlusion: an evidence-based systematic review" 117 : 1113-1123, 2010

      10 Rogers SL, "Natural history of branch retinal vein occlusion: an evidence-based systematic review" 117 : 1094-1101, 2010

      11 Chen SD, "Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion" 141 : 876-883, 2006

      12 오주연, "Early versus Late Intravitreal Triamcinolone Acetonide for Macular Edema associated with Branch Retinal Vein Occlusion" 대한안과학회 21 (21): 18-20, 2007

      13 Fine SL, "Early detection of extrafoveal neovascular membranes by daily central field evaluation" 92 : 603-609, 1985

      14 김진영, "Comparison Between Intravitreal Bevacizumab and Triamcinolone for Macular Edema Secondary to Branch Retinal Vein Occlusion" 대한안과학회 23 (23): 259-265, 2009

      15 Scott IU, "A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6" 127 : 1115-1128, 2009

      16 Ip MS, "A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion:the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5" 127 : 1101-1114, 2009

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2024 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2021-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2020-01-01 평가 등재학술지 선정 (재인증) KCI등재
      2019-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2010-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2009-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2007-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.11 0.11 0.12
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.1 0.13 0.482 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼